Get the Stockscreener App
4.52
3.21%
-0.15
After Hours:
4.60
0.08
+1.77%
Reshape Lifesciences Inc Stock (RSLS) Forecast
The Reshape Lifesciences Inc (RSLS) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $61.88, representing a +1,269% increase from the current price of $4.52. The highest analyst price target is $61.60, and the lowest is $62.17.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month RSLS Price Target
Average 69.87
(+1,446% Upside)
Is Reshape Lifesciences Inc (RSLS) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 44.78 | Neutral |
| STOCH(9,6) | 43.93 | Neutral |
| STOCHRSI(14) | 34.98 | Neutral |
| MACD(12,26) | -0.0823 | Buy |
| ADX(14) | 18.77 | Neutral |
| William %R | -78.82 | Neutral |
| CCI(14) | -29.33 | Neutral |
Buy: 1
Sell: 0
Neutral: 6
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
4.726
Sell
|
4.686
Sell
|
| MA20 |
4.6085
Sell
|
4.7187
Sell
|
| MA50 |
5.0333
Sell
|
5.1179
Sell
|
| MA100 |
5.9669
Sell
|
6.1922
Sell
|
| MA200 |
8.5392
Sell
|
8.4621
Sell
|
Buy: 0
Sell: 10
Neutral: 0
Summary: Sell
According to our latest analysis, RSLS could be considered a Strong Sell, with 17 technical analysis indicators signaling 1 Buy signals, 10 signaling Sell signals and 6 Neutral signals. This might not be a good time to consider opening new positions on RSLS, as trading bearish markets can be challenging and may result in losses.
- RSI (Relative Strength Index): The RSI(14) value of 44.78 indicates that RSLS is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 43.93 indicates that RSLS is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 34.98 indicates that RSLS is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- ADX (Average Directional Index): The ADX value of The ADX value of 18.77 indicates that there is no clear directional movement, and the market may be ranging or moving sideways.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -29.33 indicates that RSLS is not in oversold or overbought territory. It suggests a neutral sentiment in the short term.
Long-term RSLS price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Reshape Lifesciences Inc financial reports and earnings history, Reshape Lifesciences Inc (RSLS) stock could reach $63.83 by 2030, $782.50 by 2040 and $1,126.90 by 2050. See the projected annual prices until 2050 of the Reshape Lifesciences Inc stock below:
- Reshape Lifesciences Inc (RSLS) is expected to reach an average price of $357.16 in 2035, with a high prediction of $367.09 and a low estimate of $357.62. This indicates an $7,802% rise from the last recorded price of $4.52.
- Reshape Lifesciences Inc (RSLS) stock is projected to chart a bullish course in 2040, with an average price target of $794.00, representing an $17,466% surge from its current level. The forecast ranges from a conservative $5.5114 to a sky-high $782.50.
- Our analysts predict Reshape Lifesciences Inc (RSLS) to jump 9,896% by 2045, soaring from $452.24 to an average price of $451.83, potentially reaching $470.70. While $452.24 is the low estimate, the potential upside is significant.
- Reshape Lifesciences Inc (RSLS) stock is expected to climb by 2050, reaching an average of $1,107.78, a $24,408% jump from its current level. However, a wide range of estimates exists, with high and low targets of $1,126.90 and $1,111.78, respectively, highlighting the market's uncertainty.
Reshape Lifesciences Inc Stock (RSLS) Year by Year Forecast
Reshape Lifesciences Inc Stock (RSLS) Price Forecast for 2025
Reshape Lifesciences Inc Stock (RSLS) is expected to reach an average price of $69.87 in 2025, with a high prediction of $77.57 and a low estimate of $62.17. This indicates an +1,446% rise from the last recorded price of $4.52.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| February, 2025 | $70.30 | $62.17 | $61.60 | +1,455% |
| March, 2025 | $73.53 | $76.33 | $75.66 | +1,527% |
| April, 2025 | $76.55 | $70.07 | $71.61 | +1,594% |
| May, 2025 | $76.62 | $77.52 | $77.57 | +1,595% |
| June, 2025 | $76.63 | $76.19 | $74.15 | +1,595% |
| July, 2025 | $77.86 | $78.38 | $76.41 | +1,623% |
| August, 2025 | $78.03 | $76.73 | $75.54 | +1,626% |
| September, 2025 | $73.85 | $74.87 | $74.14 | +1,534% |
| October, 2025 | $76.79 | $73.63 | $72.80 | +1,599% |
| November, 2025 | $73.97 | $73.97 | $73.92 | +1,536% |
| December, 2025 | $67.95 | $68.52 | $72.22 | +1,403% |
Reshape Lifesciences Inc Stock (RSLS) Price Forecast for 2026
The predicted value for Reshape Lifesciences Inc (RSLS) in 2026 is set at an average of $45.67. Estimates vary from a peak of $66.25 to a trough of $25.09, indicating an +910.45% surge from the present price of $4.52.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $66.74 | $66.67 | $66.25 | +1,377% |
| February, 2026 | $63.42 | $63.84 | $65.29 | +1,303% |
| March, 2026 | $61.45 | $61.52 | $62.63 | +1,260% |
| April, 2026 | $56.80 | $56.88 | $60.07 | +1,157% |
| May, 2026 | $52.89 | $52.91 | $55.42 | +1,070% |
| June, 2026 | $49.76 | $49.79 | $51.80 | +1,001% |
| July, 2026 | $45.18 | $45.28 | $48.67 | +899.46% |
| August, 2026 | $41.53 | $41.68 | $44.18 | +818.82% |
| September, 2026 | $37.15 | $37.19 | $40.55 | +721.98% |
| October, 2026 | $33.73 | $33.78 | $36.15 | +646.14% |
| November, 2026 | $29.91 | $29.93 | $32.73 | +561.65% |
| December, 2026 | $25.09 | $25.09 | $28.92 | +455.06% |
Reshape Lifesciences Inc Stock (RSLS) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Reshape Lifesciences Inc (RSLS) is $94.67, with a high forecast of $188.36 and a low forecast of $0.9742. This indicates an +1,994% increase from the last price of $4.52.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $21.20 | $21.21 | $24.06 | +369.06% |
| February, 2027 | $17.38 | $17.38 | $20.21 | +284.41% |
| March, 2027 | $12.59 | $12.59 | $16.40 | +178.54% |
| April, 2027 | $8.7116 | $8.7128 | $11.60 | +92.73% |
| May, 2027 | $4.8395 | $4.8441 | $7.7155 | +7.07% |
| June, 2027 | $158.67 | $0.9742 | $147.17 | +3,410% |
| July, 2027 | $147.93 | $149.36 | $134.30 | +3,173% |
| August, 2027 | $158.19 | $160.49 | $152.37 | +3,400% |
| September, 2027 | $156.51 | $157.95 | $150.75 | +3,363% |
| October, 2027 | $183.77 | $157.08 | $180.77 | +3,966% |
| November, 2027 | $177.53 | $184.03 | $181.40 | +3,828% |
| December, 2027 | $199.86 | $180.10 | $188.36 | +4,322% |
Reshape Lifesciences Inc Stock (RSLS) Price Forecast for 2028
In 2028, Reshape Lifesciences Inc (RSLS) is projected to reach an average price of $179.65, with a high projection of $199.49 and a low estimate of $159.81. This indicates an +3,875% rise from the last price of $4.52.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $199.12 | $203.12 | $199.49 | +4,305% |
| February, 2028 | $199.88 | $198.18 | $197.38 | +4,322% |
| March, 2028 | $185.20 | $185.64 | $197.94 | +3,997% |
| April, 2028 | $191.71 | $181.33 | $186.90 | +4,141% |
| May, 2028 | $174.26 | $185.32 | $190.96 | +3,755% |
| June, 2028 | $186.12 | $181.50 | $183.56 | +4,018% |
| July, 2028 | $181.63 | $182.25 | $184.16 | +3,918% |
| August, 2028 | $178.59 | $178.88 | $176.75 | +3,851% |
| September, 2028 | $172.39 | $173.39 | $175.26 | +3,714% |
| October, 2028 | $169.07 | $170.15 | $168.83 | +3,640% |
| November, 2028 | $160.48 | $160.87 | $165.17 | +3,450% |
| December, 2028 | $158.97 | $159.81 | $158.11 | +3,417% |
Reshape Lifesciences Inc Stock (RSLS) Price Forecast for 2029
The 2029 price forecast for Reshape Lifesciences Inc Stock (RSLS) is $111.11 on average, with a high prediction of $156.30 and a low estimate of $65.92. This represents an +2,358% increase from the previous price of $4.52.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $150.32 | $151.56 | $156.30 | +3,226% |
| February, 2029 | $141.46 | $141.96 | $144.08 | +3,030% |
| March, 2029 | $136.59 | $137.76 | $139.25 | +2,922% |
| April, 2029 | $130.50 | $130.65 | $134.26 | +2,787% |
| May, 2029 | $121.47 | $121.60 | $128.58 | +2,587% |
| June, 2029 | $114.05 | $114.11 | $118.14 | +2,423% |
| July, 2029 | $106.17 | $106.32 | $111.83 | +2,249% |
| August, 2029 | $97.58 | $97.66 | $104.17 | +2,059% |
| September, 2029 | $89.86 | $89.88 | $95.42 | +1,888% |
| October, 2029 | $80.67 | $80.68 | $87.83 | +1,685% |
| November, 2029 | $73.27 | $73.29 | $78.71 | +1,521% |
| December, 2029 | $65.91 | $65.92 | $71.28 | +1,358% |
Reshape Lifesciences Inc Stock (RSLS) Price Forecast for 2030
Reshape Lifesciences Inc Stock (RSLS) is expected to reach an average price of $162.63 in 2030, with a high forecast of $323.16 and a low forecast of $2.1085. This signifies an +3,498% surge from the last price of $4.52.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $56.21 | $56.23 | $63.83 | +1,144% |
| February, 2030 | $48.46 | $48.49 | $54.26 | +972.08% |
| March, 2030 | $40.74 | $40.75 | $46.18 | +801.35% |
| April, 2030 | $33.02 | $33.02 | $38.73 | +630.50% |
| May, 2030 | $23.38 | $23.41 | $31.08 | +417.36% |
| June, 2030 | $15.63 | $15.65 | $21.44 | +245.76% |
| July, 2030 | $5.9687 | $5.9734 | $13.68 | +32.05% |
| August, 2030 | $317.10 | $2.1085 | $306.00 | +6,915% |
| September, 2030 | $313.49 | $304.89 | $297.49 | +6,836% |
| October, 2030 | $290.97 | $316.18 | $304.43 | +6,337% |
| November, 2030 | $299.86 | $302.36 | $293.86 | +6,534% |
| December, 2030 | $329.76 | $315.96 | $323.16 | +7,195% |
0.25%
0.57%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):